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An Adaptation To Life In Acid 
Through A Novel Mevalonate 
Pathway
Jeffrey M. Vinokur*, Matthew C. Cummins*, Tyler P. Korman & James U. Bowie
Extreme acidophiles are capable of growth at pH values near zero. Sustaining life in acidic environments 
requires extensive adaptations of membranes, proton pumps, and DNA repair mechanisms. Here 
we describe an adaptation of a core biochemical pathway, the mevalonate pathway, in extreme 
acidophiles. Two previously known mevalonate pathways involve ATP dependent decarboxylation 
of either mevalonate 5-phosphate or mevalonate 5-pyrophosphate, in which a single enzyme carries 
out two essential steps: (1) phosphorylation of the mevalonate moiety at the 3-OH position and (2) 
subsequent decarboxylation. We now demonstrate that in extreme acidophiles, decarboxylation 
is carried out by two separate steps: previously identified enzymes generate mevalonate 
3,5-bisphosphate and a new decarboxylase we describe here, mevalonate 3,5-bisphosphate 
decarboxylase, produces isopentenyl phosphate. Why use two enzymes in acidophiles when one 
enzyme provides both functionalities in all other organisms examined to date? We find that at low 
pH, the dual function enzyme, mevalonate 5-phosphate decarboxylase is unable to carry out the 
first phosphorylation step, yet retains its ability to perform decarboxylation. We therefore propose 
that extreme acidophiles had to replace the dual-purpose enzyme with two specialized enzymes to 
efficiently produce isoprenoids in extremely acidic environments.
Extremophiles are organisms capable of surviving in the harshest conditions on earth such as temperatures 
exceeding 120 °C in hydrothermal vents, salinity exceeding 5 M NaCl in evaporating lakes, and acidity below pH 0 
in acid mine drainage1–3. The vast majority of extremophiles belong to the archaeal domain of life, having adapted 
to conditions prevalent on a primordial earth4. Growth in extremely acidic conditions is especially challenging as 
the organism must maintain a 100,000 fold H+ gradient across its membrane while allowing for the import and 
export of metabolites and other molecules5.
The lowest pH to support life so far recorded is pH − 0.06 (1.2 M sulfuric acid) by Picrophilus torridus, a 
member of the archaeal order thermoplasmatales6. This unique order contains only 11 characterized organisms, 
all of which are extreme acidophiles capable of growth at pH 0.5 and below6–9. Thermoplasmatales have among 
the smallest genomes of any free living organism (< 2 Mb), reversed membrane potentials, and all but P. torridus 
lack a cell wall entirely5. The first line of defense against acidity in thermoplasmatales is a highly impermeable 
lipid monolayer made of C40 tetra-ether lipids10. The C40 alkyl chains are made entirely from tandem repeats 
of 5-carbon isoprene units, and are connected to polar head groups through ether linkages10. Isoprenoid based 
lipids pack more tightly, making archaeal membranes less permeable to small molecules and the ether linkages 
impart acid stability11.
The 5-carbon precursor for all isoprenoids, isopentenyl pyrophosphate (IPP), is generated by the meva-
lonate pathway in eukaryotes, archaea, and some bacteria12. All known mevalonate pathways first produce 
(R)-mevalonate through the condensation of three acetyl-CoA molecules followed by a reduction step to yield 
mevalonate (Fig. 1). In eukaryotes, mevalonate is then phosphorylated twice at the 5-OH position to generate 
mevalonate 5-pyrophosphate, then decarboxylated to yield IPP (Fig. 1, black pathway)13. In most archaea how-
ever, mevalonate is phosphorylated once to make mevalonate 5-phosphate (M5P), then decarboxylated to iso-
pentenyl phosphate (IP), and finally phosphorylated again to generate IPP (Fig. 1, blue pathway)14,15. In both the 
eukaryotic and classical archaeal pathways, decarboxylation is ATP-dependent and proceeds in two sequential 
steps via a single enzyme: (1) phosphorylation at the 3-OH position of the mevalonate moiety using ATP and 
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(2) decarboxylation (Fig. 2)16. Thus, the decarboxylases are dual function enzymes. The phosphorylation step 
adds a phosphate group to the 3-OH position, which acts as a good leaving group and primes the molecule for 
decarboxylation16.
We and another group recently discovered two new enzymes in Thermoplasma acidophilum, mevalonate 
3-kinase (EC 2.7.1.185) and mevalonate 3-phosphate 5-kinase (EC 2.7.1.186), whose sequential catalysis pro-
duces mevalonate 3,5-bisphosphate from mevalonate suggesting that there may be another route to produce 
isoprenoids besides the canonical archaeal pathway (Fig. 1, red pathway)17,18. However, the putative mevalonate 
3,5-bisphosphate decarboxylase (MBD) remained unidentified to complete this alternative archaeal pathway. 
Here we report the identification of MBD from T. acidophilum, which produces IP through the ATP independent 
decarboxylation of mevalonate 3,5-bisphosphate (Fig. 2, reaction in brackets).
The new pathway is particularly odd, because the 3-OH phosphorylation and subsequent decarboxylation are 
carried out by two distinct enzymes even though both enzymes are structurally homologous to dual-function 
decarboxylases. Thus, it appears that the two enzymes evolved from a dual function decarboxylase, but became 
specialized. Why? We show that the new pathway is only present in extreme acidophiles, suggesting that low pH 
may require divergent activities. Indeed we find that the dual function mevalonate 5-phosphate decarboxylase 
(MMD) from Roseiflexus castenholzii is unable to carry out the kinase step at low pH, but retains decarboxylase 
Figure 1. Mevalonate pathways. Eukaryotes use the pathway shown in black while most archaea use the 
pathway shown in blue. Here we have identified mevalonate 3,5-bisphosphate decarboxylase (bold arrow) which 
confirms a third route present in extreme acidophiles (red).
www.nature.com/scientificreports/
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activity. Thus, it is possible that a separate enzyme became specialized to handle the kinase function at low pH. 
This adaptation could have evolved through a duplication or horizontal transfer event, followed by specialization 
to support life in extremely acidic environments.
Results
Sequence homology suggests that Ta0893 is a decarboxylase.  To search for mevalonate 3,5- 
bisphosphate decarboxylase (MBD) in Thermoplasma acidophilum, we identified proteins homologous to decar-
boxylases. Two proteins from the archeon Thermoplasma acidophilum, Ta1305 and Ta0893, were computationally 
annotated in the year 2000 as “mevalonate pyrophosphate decarboxylase”9. As reported recently, however, Ta1305 
is actually mevalonate 3-kinase (EC 2.7.1.185)17. A structural homology model of Ta0893 made with PHYRE2 
suggested significant similarity to mevalonate 5-pyrophosphate decarboxylase from yeast (PDB: 1FI4, confidence 
score of 100%) and contained the invariant Asp/Lys/Arg catalytic triad necessary for decarboxylation in the cor-
rect positions (Fig. 3)19–21. Unfortunately, Ta0893 consistently formed inclusion bodies when expressed in E. coli 
and no activity could be detected in extracts. As a result we set out to find the putative missing decarboxylase via 
direct purification from T. acidophilum.
Identification of MBD activity in T. acidophilum lysate.  Following growth of Thermoplasma acido-
philum, we were able to detect MBD activity in crude lysate using mevalonate 3,5-bisphosphate as a substrate. To 
initially fractionate the lysate, we separated the T. acidophilum lysate by anion exchange chromatography using a 
HiTrap Q HP column. Ten fractions were collected and assayed for MBD activity18. As shown in Fig. 4A, fraction 
7 showed the highest MBD activity, so we further separated fraction 7 in two side-by-side lanes on a native poly-
acrylamide gel. Coomassie blue staining (detection limit: ~5 ng) of one lane revealed 25 distinct bands. The adja-
cent gel lane (unstained) was then cut into 19 fragments (Fig. 4B), pulverized and assayed for MBD activity. As 
shown in Fig. 4C, MBD activity was detected in gel fragments 13–16. Each fragment was independently analyzed 
Figure 2. The reaction scheme. Mevalonate 5-phosphate decarboxylase of the classical archaeal pathway 
employs a two-step mechanism: (1) phosphorylation using ATP and (2) decarboxylation. The enzyme reported 
here, mevalonate 3,5-bisphosphate decarboxylase, carries out only the second step shown in brackets.
Figure 3. Ta0893 possesses key residues for decarboxylation. A PHYRE model of Ta0893 is overlayed with 
mevalonate pyrophosphate decarboxylase from S. epidermidis containing bound mevalonate 5-pyrophosphate 
(PDB: 4DU7). Numbered Ta0893 residues are highlighted in yellow and mevalonate pyrophosphate 
decarboxylase residues are shown in blue.
www.nature.com/scientificreports/
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by NanoLC/MS/MS for protein identification. The results revealed that Ta0893 and 6 other proteins were present 
in all 4 gel fragments (Table 1), suggesting that one of them might be the missing decarboxylase.
Ta0893 shows decarboxylase activity when truncated or co-expressed with chaperones.  
Identification of Ta0893 through mass spectrometry combined with clear homology motivated a larger effort to 
produce active, soluble Ta0893 in E. coli. Nevertheless, all attempts to refold Ta0893 from inclusion bodies failed 
after varying many parameters such as pH, temperature, salts, substrates, and screening using the Quickfold 
kit from Athena Enzyme Systems22. We were finally able to detect MBD activity in Ni-NTA eluates under 
two expression conditions in E. coli: (1) truncating Ta0893 by removing 30 AAs from the N-terminus and (2) 
co-expression of the full-length Ta0893 protein with E. coli chaperones, GroES/GroEL (Fig. 4D)23. We chose to 
truncate 30 AAs from the N-terminus of Ta0893 because this region was not present in the Ta0893 homolog from 
Thermoplasma volcanium, suggesting the first 30 AAs were not required for function. Size exclusion chroma-
tography showed that the apparent molecular weight of MBD activity is 89± 4 kDa in both recombinant Ta0893 
co-expressed with chaperones as well as T. acidophilum lysate (Fig. 4E). The predicted molecular weight of a 
Ta0893 monomer is 46.3 kDa, suggesting that Ta0893 is a native homodimer. The finding that MBD activity in 
E. coli is dependent on Ta0893 expression and correlates with the same molecular weight as activity in T. acido-
philum lysate, strongly suggests that Ta0893 is the missing MBD.
Ta0893 produces isopentenyl phosphate.  To confirm that recombinant Ta0893 produces isopentenyl 
phosphate (IP), we coupled MBD activity to IP kinase from T. acidophilum which specifically phosphorylates IP24. 
Figure 4. Purification and identification of MBD. (A) MBD activity in anion exchange fractions of a  
T. acidophilum lysate. (B) Native gel separation of fraction 7 from anion exchange. (C) The native gel was cut 
into 19 fragments, pulverized, and tested for MBD activity. (D) Units are in umoles/mg total protein. MBD 
activity in crude extracts with various N-terminal truncations of Ta0893 expressed in E. coli or when the full 
length protein was co-expressed with GroEL/ES (Gro). (E) T. acidophilum lysate (black) and recombinant 
Ta0893 co-expressed with GroEL/ES (blue) were separated on a Superdex S200 gel filtration column. The MBD 
activity peaked at the same volume in both samples, consistent with the identification of Ta0893 as the native 
MBD. (F) Addition of IP kinase to the product of Ta0893 causes rapid consumption of ATP (black) suggesting 
that Ta0893 produces IP. A negative control omitted Ta0893 (blue).
www.nature.com/scientificreports/
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Robust ATP consumption was detected when IP kinase was added to a reaction containing Ta0893 pre-incubated 
with (R)-mevalonate 3,5-bisphosphate (Fig. 4F).
Other extreme acidophiles also display MBD activity.  While we confirmed that Ta0893 is a bona 
fide MBD, the lack of robust Ta0893 expression led us to seek close homologs better suited for recombinant 
expression to characterize the biochemical properties of MBD. A BLASTp search for homologs of Ta0893 reveals 
only 8 organisms containing an MBD homolog with greater than 30% sequence identity. Indeed, these 8 organ-
isms represent all the sequenced thermoplasmatales. We cloned each MBD homolog (Thermoplasma volcanium, 
Picrophilus torridus, Ferroplasma acidarmanus, Ferroplasma sp. Type II, and Acidiplasma sp. MBA-1), into 
E. coli expression vectors. Using standard expression conditions, we observed activity in Ni-NTA eluates for the 
T. volcanium and P. torridus MBD homologs (Fig. 5). MBD homologs from Ferroplasma and Acidiplasma formed 
inclusion bodies under all tested expression conditions.
The specialized mevalonate pathway is unique to thermoplasmatales.  A BLASTp search using 
MBD from T. acidophilum (Ta0893) shows strong sequence identity for all 8 sequenced thermoplasmatales. 
This includes Acidiplasma sp. MBA-1 (68%), Acidiplasma aeolicum (68%), Acidiplasma cupricumulans (68%), 
Thermoplasma volcanium (63%), Ferroplasma sp. Type II (50%), Ferroplasma acidarmanus (48%), and Picrophilus 
torridus (40%) (Fig. 6A). The next strongest alignments (29%) after thermoplasmatales are proteins from eubac-
teria of the phylogenetic family chloroflexaceae. Indeed, the chlorflexaceae Roseiflexus castenholzii is known to 
contain a bona fide MMD of the canonical archaeal mevalonate pathway14. Sequence alignment of T. acidophilum 
MBD against classical mevalonate pathway decarboxylases shows retention of the invariant Asp/Lys/Arg catalytic 
Hits Prot. Mass (kDa) Peptides Protein Annotation NCBI Accession Rel. Abund.
1 37.7 107 Deoxyhypusine Synthase (Ta0356) WP_010900784 83.5%
2 44.4 9 S-adenosylmethionine Synth. (Ta0059) WP_010900487 8.4%
3 46.4 4 Hypothetical Protein (Ta0893) WP_010901303 0.4%
4 51.1 4 Glutamine Synthetase (Ta1498) WP_010901897 0.6%
5 55.0 1 Hypothetical Protein (Ta0203) WP_010900630 0.2%
6 45.0 1 Hypothetical Protein (Ta0204) WP_010900631 0.1%
7 35.5 1 DNA Repair Protein RadA (Ta1104) WP_010901514 0.0%
Table 1.  Proteins identified in gel fragments with MBD activity. NanoLC/MS/MS identified seven proteins 
which were present in the entire region of MBD activity (gel fragments 13–16, Fig. 4B). The relative abundance 
is reported for fragment 14.
Figure 5. Activity of Ta0893 homologs. Five Ta0893 homologs were his-tag purified and incubated with 
mevalonate 3,5-bisphosphate to detect MBD activity. Homologs from Ferroplasma and Acidiplasma formed 
inclusion bodies under all expression conditions. The MBD homolog from Acidiplasma sp. MBA-1 has the 
identical amino acid sequence as A. aeolicum and is 99.7% identical (1AA substitution) to A. cupricumulans.  
We cloned the MBA-1 homolog to represent all 3 species of the Acidiplasma genus. NCBI accession numbers:  
T. acidophilum (WP_010901303.1), T volcanium (WP_010916684.1), P. torridus (WP_010917040.1),  
F. acidarmanus (WP_009887850.1), F. sp. Type II (EQB73519.1), and A. sp. MBA-1 (WP_048100791.1).
www.nature.com/scientificreports/
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triad required for decarboxylation, however MBDs are unique in that they are missing both nearly invariant ATP 
binding residues (Fig. 6B)19,25–27. Indeed, unlike all other mevalonate pathway decarboxylases, MBD does not 
require ATP. MBD’s complement, mevalonate 3-kinase (Ta1305) has equally strong homologs (39–67% ID) in 
all 8 thermoplasmatales yet has no detectable homologs in any other organism, suggesting that this pathway is 
unique to thermoplasmatales.
Biochemical characterization of MBD from Picrophilus torridus.  Since the P. torridus MBD 
showed robust expression in E. coli, we chose to purify this enzyme for further characterization (Fig. 7A) and 
Figure 6. Phylogeny and Sequence Alignment. (A). A phylogenetic tree of thermoplasmatales based on 
16 S rRNA. Organisms with no available DNA sequences are shown in grey. Environmental samples were 
excluded for clarity. (B) Mevalonate 3,5-bisphosphate decarboxylase homologs representing all 8 sequenced 
thermoplasmatales were aligned with mevalonate 5-phosphate decarboxylases (MMD), mevalonate 
5-pyrophosphate decarboxylases (MPD), and the top Ta0893 BLASTp hits after thermoplasmatales. MBDs 
retain the Asp/Lys/Arg catalytic triad required for decarboxylation (red), but are missing both ATP binding 
residues (purple).
Figure 7. Purification of P. torridus MBD and Substrate Specificity. (A) An SDS-PAGE gel stained with 
Coomassie blue. Lanes: (L) ladder, (1) crude E. coli lysate, (2) Ni-NTA eluate, (3) supernatant after heating for 
2 hrs at 60 °C, (4) flow through from a Q HP anion exchange column. Yield was 1 mg purified P. torridus MBD 
from 32 L of culture. (B). P. torridus MBD (black) and R. castenholzii mevalonate 5-phosphate decarboxylase 
(blue) were assayed via our GC-FID decarboxylase assay after incubation with the following substrates 
for 1 hour: (MEV) mevalonate, (M3P) mevalonate 3-phosphate, (M5P) mevalonate 5-phosphate, (MBP) 
mevalonate 3,5-bisphosphate, (MPP) mevalonate 5-pyrophosphate and (NS) no substrate.
www.nature.com/scientificreports/
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compare it to the classical mevalonate 5-phosphate decarboxylase (MMD) from Roseiflexus castenholzii14. 
Roseiflexus castenholzii is a member of the chloroflexaceae family whose MMDs are most closely related to MBDs 
of Thermoplasmatales and are therefore the closest known evolutionary precursors. Purified P. torridus MBD 
showed clear specificity for mevalonate 3,5-bisphosphate and no detectable decarboxylase activity on mevalonate, 
mevalonate 3-phosphate, mevalonate 5-phosphate or mevalonate 5-pyrophosphate (Fig. 7B, black bar). P. torri-
dus MBD worked optimally at 70 °C and a pH around 5 where it had a kcat of approximately 7.0 s−1 with respect to 
(R)-mevalonate 3,5-bisphosphate (Supplemental Figs 1–3). This kcat value is comparable to R. castenholzii MMD 
(1.7 ± 0.1 s−1)14. Interestingly, R. castenholzii MMD was also active on mevalonate 3,5-bisphosphate when sup-
plied with ADP as a co-factor (Fig. 7B, blue bars). We were unable to accurately determine the Km for MBD since 
it was still at Vmax when assayed at the detection limit of our GC-FID assay (30 μ M).
MMD loses kinase function at low pH.  We characterized the previously un-reported activity of MMD on 
its reaction intermediate (mevalonate 3,5-bisphosphate) and compared it to its native substrate. Interestingly, at 
low pH, MMD completely loses its ability to convert mevalonate 5-phosphate to IP (its native reaction), but con-
tinues to decarboxylate mevalonate 3,5-bisphosphate, effectively becoming a MBD at low pH because it cannot 
perform the first kinase step (Fig. 8). The fact that decarboxylase activity remains intact suggests that low pH does 
not cause global inactivation or unfolding of the enzyme. These results suggest that low pH requires specialization 
to provide a kinase function. The adaptation could come in the form of adjustments to the normal MMD or the 
evolution of a new kinase.
Discussion
The novel decarboxylase reported here demonstrates a unique mevalonate pathway in T. acidophilum. While the 
classical archaeal pathway phosphorylates mevalonate at the 5-OH position to yield mevalonate 5-phosphate, 
and then uses MMD to produce IP in an ATP dependent reaction, the T. acidophilum pathway produces the same 
end product, but uses a different set of enzymes and metabolites17. The pathway in T. acidophilum phosphorylates 
mevalonate at the 3-OH position and the 5-OH position sequentially by two distinct enzymes to yield mevalonate 
3,5-bisphosphate. This is followed by the action of MBD which carries out ATP independent decarboxylation to 
produce IP. Both archaeal pathways use IP kinase to produce IPP (Fig. 1, blue and red routes)24.
Localization of this unique pathway to the most acid tolerant organisms on earth suggests that the pathway 
may confer an evolutionary advantage in extremely acidic environments. P. torridus has an internal pH of 4.6 
while T. acidophilum and F. acidarmanus have an internal pH of 5.5 and 5.6 respectively28–30. We observe that at 
pH 4.3, the conversion of mevalonate 5-phosphate by MMD stops completely, while the decarboxylation activity 
of mevalonate 3,5-bisphosphate by MMD remains intact. We propose that the common ancestor of thermoplas-
matales also had a low internal pH and the classical decarboxylation reaction was inefficient, which would have 
applied evolutionary pressure to adapt. One possible way to adapt would be to find a way to make both the kinase 
and decarboxylation steps more effective at low pH. The fact that such a seemingly simple adaptation did not 
occur, suggests that it may be difficult to accomplish. Interestingly, a different evolutionary pathway was chosen 
by thermoplasmatales and two separate enzymes developed. We propose a model in which a horizontal trans-
fer or a gene duplication event placed two MMD enzymes into the common ancestor and over time these two 
enzymes became specialized9,31. One lost its decarboxylase function to become a mevalonate 3-kinase, and the 
second lost its kinase function to become a dedicated decarboxylase (MBD). These two specialized enzymes were 
more efficient at low pH than a single dual-function enzyme. One possible explanation for the kinase function 
of R. castenholzii MMD stopping while decarboxylation continues at low pH could be the acidity perturbing the 
Figure 8. pH dependence of activity of R. castenholzii MMD with native substrate (mevalonate 
5-phosphate) or intermediate (mevalonate 3,5-bisphosphate). Mevalonate 5-phosphate decarboxylase was 
assayed at 50 °C over a pH range of 4.3-9.1 with 10 mM mevalonate 5-phosphate (black) or 10 mM mevalonate 
3,5-bisphosphate (blue).
www.nature.com/scientificreports/
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protonation state of an active site residue that deprotonates the 3-OH group of mevalonate and triggers nucleop-
hilic attack on the γ -phosphate of ATP.
One peculiar observation is that the two specialized functions do not act in tandem, but are one step removed, 
with mevalonate 3-phosphate 5-kinase acting between the 3-OH phosphorylation of mevalonate and the decar-
boxylation by MBD. The reason for this is unclear.
Decarboxylation in the mevalonate pathway has been extensively studied in the eukaryotic homolog, meva-
lonate 5-pyrophosphate decarboxylase, which converts mevalonate 5-pyrophosphate to IPP in an ATP-dependent 
manner16,21,32–35. The mechanism was previously thought to occur via a single step in which the phosphorylation 
of the 3-OH position leads to an unstable and transient intermediate that rapidly decomposes into IPP, CO2 and 
PO426,27. Our previous identification of mevalonate 3,5-bisphosphate as a stable metabolite suggested that decar-
boxylation is not spontaneous and must be carried out by enzyme catalysis17,36. The identification of MBD pro-
vides further support for the two-step model since T. acidophilum carries out the reactions through two entirely 
separate enzymes. Furthermore, we show that MMD from Roseiflexus castenholzii can accept its intermediate, 
mevalonate 3,5-bisphosphate, and carry out the second step of its dual function independently of the first step. 
These results strongly indicate that decarboxylation is catalyzed, not spontaneous, and that the ATP dependent 
decarboxylases operate via a two-step mechanism.
One unexpected finding of our study is that MMD from Roseiflexus castenholzii requires ADP as a 
co-factor to decarboxylate mevalonate 3,5-bisphosphate. We propose that ADP binding is necessary to form 
the active enzyme-substrate complex. Structural analysis of mevalonate 5-pyrophosphate decarboxylase from 
Staphylococcus epidermidis showed that ATP binding triggers two flexible loops to close over the substrates in the 
active site pocket32. We suggest that ADP is necessary as a co-factor to mimic the presence of the native substrates 
(mevalonate 5-phosphate and ATP), which would trigger loop closure and form the active complex. After decar-
boxylation, the loops would presumably transition to an open state and release IP, ADP, CO2 and PO4. Sequence 
alignment with mevalonate pyrophosphate decarboxylases shows that MBD does not contain two nearly invariant 
amino acids that bind the adenine ring of ATP (Fig. 6B)37. Presumably, the specialization of MBD to become a 
dedicated decarboxylase involved the loss of its ADP requirement.
In summary, we have identified and characterized mevalonate 3,5-bisphosphate decarboxylase, a novel 
enzyme which produces isopentenyl phosphate and completes the unique mevalonate pathway of extreme aci-
dophiles comprising the archaeal order thermoplasmatales. We also report that the two steps of the mevalonate 
5-phosphate decarboxylase mechanism can be separated as demonstrated by the robust activity of MMD directly 
on its intermediate, mevalonate 3,5-bisphosphate. Indeed, at pH values representative of the P. torridus cytoplasm 
(~4.6), MMD loses its kinase function completely and becomes a decarboxylase only. We propose that thermo-
plasmatales adapted their mevalonate pathway by replacing MMD with two specialized enzymes in order to 
produce isoprenoids in extremely acidic environments.
Methods
Materials.  E. coli BL21(DE3) Gold (Agilent) was grown in Miller LB media (Fisher) for both cloning and 
expression of recombinant proteins. Plasmid pET28a(+ ) was purchased from Novagen and pBB541 encoding 
GroEL/GroES was obtained from Addgene23. Ni-NTA resin was purchased from Qiagen. Native gels were pur-
chased from Expedeon. All other chemicals were purchased from Sigma-Aldrich unless otherwise noted.
Thermoplasma acidophilum growth.  Thermoplasma acidophilum was obtained as a live culture from 
NITE Biological Resource Center (Tokyo, Japan). The organism was grown in NBRC medium 280 at 60 °C to 
OD600 = 0.5. Cells were harvested by centrifugation at 5000 × g. 2 g of wet cell pellet (4 L culture) were resus-
pended in 20 mL of 50 mM sodium phosphate buffer [pH 6.5]. The cells were chilled on ice for 30 min and then 
lysed by sonication. A cell-free lysate was obtained after centrifugation at 30,000 × g.
Anion exchange chromatography.  Initial separation of the T. acidophilum lysate was adapted from the 
procedure of another research group18. In brief, 10 mL of T. acidophilum lysate was applied to a 1 mL HiTrap 
Q HP anion exchange column (strong quaternary ammonium anion exchanger) pre-equilibrated with 50 mM 
sodium phosphate buffer [pH 6.5], connected to an AKTA FPLC system. The column was washed with 20 mL 
of 50 mM sodium phosphate buffer [pH 6.5] followed by a gradient from 0 to 1 M NaCl over 20 min and 2 mL 
fractions were collected. A flow rate of 1 mL/min was used for all steps.
Native gels.  20 μ L of the most active fraction from anion exchange chromatography was loaded into two 
side-by-side wells of a 20% native polyacrylamide gel (Expedeon). The gel was developed by running towards the 
anode at 40 V for 50 min followed by 150 V for 16 hrs in a cold room (4 °C). One lane was stained with Expedeon 
InstantBlue protein stain. The unstained lane was cut into 19 fragments using the stained lane as a reference. Each 
gel fragment was pulverized by sonication in 500 μ L of 50 mM sodium phosphate buffer [pH 6.5] containing 
500 mM NaCl. 50 μ L of the resulting slurry was used for the GC-FID assay below.
GC-FID Decarboxylase Assay.  A 50 μ L sample of chromatography fraction was added to a 150 μ L reaction 
mixture consisting of 50 mM sodium phosphate buffer [pH 6.5], 500 mM NaCl, 10 mM (R)-mevalonate, 20 mM 
ATP, 5 mM MgCl2, 10 μ g mevalonate 3-kinase (Ta1305), and 10 μ g mevalonate-3-phosphate-5-kinase (Ta0762). 
The reaction was incubated for 24 hours at 60 °C. Any generated isopentenyl phosphate was then hydrolyzed 
into isoprenol and free phosphate by adding 100 μ L of 1 M bis-tris propane [pH 9.0], followed by 30 U of alkaline 
phosphatase from bovine intestinal mucosa. After incubation at 37 °C for 2 hours, the reaction was extracted with 
200 μ L hexanes. 5 μ L of the hexanes layer was injected into a HP5890 Series II Gas Chromatograph (flame ioni-
zation detector) connected to a HP-INNOWAX column (0.320 mm × 30 m, Agilent). The carrier gas was helium 
www.nature.com/scientificreports/
9Scientific RepoRts | 6:39737 | DOI: 10.1038/srep39737
with a flow rate of 5 mL/min. Initial oven temperature was set to 70 °C for 2 min, followed by a ramp of 20 °C/
min for 1 min, and finally a ramp at 50 °C/min to a final temperature of 200 °C, which was held for 1 min. The 
inlet was kept at 250 °C and the detector at 330 °C. Isoprenol eluted at 2.98 min and the sample concentration was 
determined by comparison to a standard. All GC-FID samples were prepared in duplicate.
Mass spectrometry.  The four native gel bands from the stained lane corresponding to the highest activities 
were excised and submitted to ProtTech Inc. for independent analysis via NanoLC/MS/MS. The following steps 
were carried out by Protech: Peptides were digested in-gel using sequencing grade modified trypsin (Promega) in 
100 mM ammonium bicarbonate [pH 8.5] buffer. DTT and iodoacetamide were added for reduction and alkyla-
tion of cysteine residues. The digested peptides were extracted with acetonitrile, dried using a Thermo SpeedVac, 
then redissolved in 2% acetonitrile, 97.5% water, and 0.5% formic acid. Peptides were separated using a high 
pressure liquid chromatography system (HPLC) fitted with a reversed-phase C18 column (75 μ M ID × 8 cm). 
Samples eluted from the HPLC column were directly ionized by electrospray ionization and analyzed by an ion 
trap mass spectrometer (LCQ DECA XP Plus, Thermo). MS/MS spectra were acquired via low energy collision 
induced dissociation. The collected mass spectrometric data were searched against the NCBI protein database 
using ProtTech’s ProtQuest software. Peptides were reported with a mass range of 550 to 1800 Da and a signal to 
noise ratio greater than or equal to 5.
General Cloning.  All genes were codon optimized and synthesized by IDT. Each gene was inserted between 
the NdeI and XhoI sites of the pET28a(+ ) vector, which allowed for the addition of an N-terminal 6xHis tag. 
Genes were synthesized with an extra 25 base-pairs complementary to the pET28a(+ ) vector at the NdeI and 
XhoI sites. A standard Gibson method was used to assemble all constructs by mixing 30 ng of synthesized DNA, 
with 10 ng of pET28a(+ ) digested with NdeI and XhoI and 7.5 μ L of Gibson assembly mix38. After incubation at 
50 °C for 2 hrs, 5 μ L was used to transform E. coli BL21(DE3) Gold and transformants were selected on LB-agar 
plates containing 50 μ g/mL kanamycin.
Expression and Purification.  Protein expression and purification was carried out as described previously17. 
In brief, 1 L of LB media was inoculated with 5 mL of E. coli overnight starter culture with 50 μ g/mL kanamycin 
and/or 100 μ g/mL spectinomycin as needed. The cells were grown to an OD600 of 0.5–1.0 and induced at 37 °C 
with 1.0 mM IPTG. After 18 hours, cells were pelleted, resuspended in 5 mL of buffer A (50 mM bis-tris propane 
[pH 7.5] buffer, 100 mM NaCl, 10 mM imidizole), lysed by sonication, and cell debris removed by centrifugation 
at 30,000 × g for 20 min. The lysate was mixed with 3 mL of a Ni-NTA slurry and incubated for 15 min at 4 °C 
with gentle mixing. The lysate mixture was packed into a column and the Ni-NTA beads were washed 3 times 
with 20 mL of buffer A. Protein was eluted with 4 mL of buffer A containing 250 mM imidazole. Co-expression 
of GroEL/GroES was achieved by the addition of plasmid pBB541 (addgene) to the expression strain23. For bio-
chemical characterization, P. torridus MBD was further purified by heating the eluate at 60 °C for 2 hrs to precip-
itate native E. coli proteins followed by one passage through a HiTrap Q HP anion exchange column to remove 
negatively charged proteins.
Coupled Enzyme Assay.  The MBD product was confirmed to be IP via coupling to IP kinase. A 100 μ L 
reaction containing 25 mM bis-tris propane buffer [pH 6.5], 5 mM (R)-mevalonate, 10 mM ATP, 5 mM KCl, 5 mM 
MgCl2, 5 μ g mevalonate 3-kinase (Ta1305), 5 μ g mevalonate 3-phosphate 5-kinase (Ta0893), and 50 μ L Ta0893 
Ni-NTA eluate (0.5 mg/mL total protein) was incubated for 24 hours at 60 °C. To measure ATP consumption, we 
added 1 μ L coupling enzyme mix (lactate dehydrogenase and pyruvate kinase mix from rabbit muscle, Sigma), 
15 mM PEP, and titrated in NADH via 0.5 mM increments to bring the OD340 to 1.0. We then recorded the OD340 
over 10 min on a SpectraMax M5 microplate reader. 5 μ g IP kinase from T. acidophilum (Ta0103) was added at 
the 5 min mark. A negative control replaced Ta0893 eluate with water.
Biochemical characterization.  The optimal pH for P. torridus MBD was determined in 0.5 pH unit incre-
ments. Mevalonate 3,5-bisphosphate was enzymatically generated by mixing 10 mM (R)-mevalonate with 20 mM 
ATP, 5 mM MgCl2, 100 mM NaCl, 10 μ g mevalonate 3-kinase (Ta1305), and 10 μ g mevalonate-3-phosphate-
5-kinase (Ta0762). After 1 hour at 60 °C, 150 μ L of this mixture was combined with 50 μ L of 1 M sodium acetate 
(for pH 3.5–5.5) or bis-tris propane buffer (for pH 6.5–8.0). pH adjustments were made using HCl and NaOH 
and confirmed using a micro pH electrode (Hanna Inst. 1083B). The reaction was initiated by the addition of 
0.1 μ g P. torridus MBD and incubated at 60 °C for 1 hour followed by transferring the vials into boiling water for 
1 min to stop the reaction. Analysis was carried out via GC-FID as described above. The optimal temperature was 
determined in the same manner with pH held constant at 5.5. The data points for optimum pH and temperature 
were confirmed to be initial rates by quenching a control reaction (pH 5.5, 60 °C) at 30, 60, 90, and 120 min as 
shown in Supplemental Fig. S3. Substrate specificity was tested by replacing (R)-mevalonate with commercially 
available (R)-mevalonate 5-phosphate, or (R)-mevalonate 5-pyrophosphate. Activity on mevalonate-3-phosphate 
was tested by omitting Ta0762. Kinetic characterization of P. torridus MBD were carried out at pH 5.5 and 70 °C 
using the GC-FID assay with 3 ng enzyme over a range of 0.03 to 5 mM (R)-mevalonate 3,5-bisphosphate. 50 μ L 
aliquots of this reaction were quenched at 0, 20, 40, and 60 minutes by boiling for 1 min. The enzyme was at Vmax 
for all substrate concentrations from 5 mM to the detection limit (30 μ M). All characterization experiments were 
carried out in duplicate.
Size exclusion chromatography.  To estimate the size of the protein complex that causes MBD activity, we 
mixed 100 μ L of T. acidophilum cell-free lysate or 100 μ L recombinant Ta0893 with 100 μ L of Biorad gel filtration 
standard and injected the mixture directly onto a Superdex S200 10/300 GL gel filtration column. The column 
was equilibrated in 50 mM sodium phosphate buffer [pH 6.5] and 500 mM NaCl at a flow rate of 0.5 mL/min. 
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0.5 mL fractions were collected and subjected to our GC-FID decarboxylase assay. Fitting the activity profile to 
a standard curve made from the internal standards allowed us to estimate the size of the MBD protein complex.
Sequence Alignment.  Ta0893 was subjected to a standard BLASTP search39. The resulting output was 
aligned using clustal omega with default parameters37. Mevalonate pyrophosphate decarboxylases from the PDB 
were also included in the alignment. The output was rendered with Espript 3.0 and edited with Macromedia 
Fireworks 2004 to highlight regions of interest40.
Analysis of MMD activity at low pH.  Roseliflexus castenholzii mevalonate 5-phosphate decarboxylase was 
assayed over a pH range of 4.3–9.1 with enzymatically generated substrates. Mevalonate 5-phosphate was pro-
duced by mixing 10 mM (R)-mevalonate with 20 mM ATP, 10 mM MgCl2, 100 mM NaCl and 20 μ g mevalonate 
5-kinase (M5K) from Methanosarcina mazei41. Mevalonate 3,5-bisphosphate was generated in an identical man-
ner except that M5K was replaced with 10 μ g of mevalonate 3-kinase (Ta1305) and 10 μ g mevalonate 3-phosphate 
5-kinase (Ta0762). After production of the substrates for 4 hr at 37 °C and 60 °C respectively, we mixed 150 μ L 
of each substrate mixture with 50 μ L of 1 M acetate buffer (pH 4.3–5.6) or bis-tris propane buffer (6.5–9.1). A 
micro pH electrode (Hanna Inst. 1083B) was used to confirm the final pH. 0.5 μ g of R. castenholzii MMD was 
then added to each reaction. After incubation at 50 °C for 1 hour, we stopped the reaction by immersing the vials 
in boiling water for 1 min and analyzed it via the GC-FID protocol above. This experiment was carried out in 
duplicate.
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